List of Excipients in API FENTANYL CITRATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing FENTANYL CITRATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA Inc | FENTANYL CITRATE | fentanyl citrate | 0093-7865 | ANHYDROUS CITRIC ACID | |
| Teva Pharmaceuticals USA Inc | FENTANYL CITRATE | fentanyl citrate | 0093-7865 | DEXTRATES | |
| Teva Pharmaceuticals USA Inc | FENTANYL CITRATE | fentanyl citrate | 0093-7865 | MAGNESIUM STEARATE | |
| Teva Pharmaceuticals USA Inc | FENTANYL CITRATE | fentanyl citrate | 0093-7865 | MODIFIED CORN STARCH | |
| Teva Pharmaceuticals USA Inc | FENTANYL CITRATE | fentanyl citrate | 0093-7865 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | |
| Teva Pharmaceuticals USA Inc | FENTANYL CITRATE | fentanyl citrate | 0093-7865 | SUCROSE | |
| Hospira Inc | FENTANYL CITRATE | fentanyl citrate | 0409-9093 | HYDROCHLORIC ACID | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing FENTANYL CITRATE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| SpecGx LLC | fentanyl citrate | 0406-9202 | ALCOHOL |
| SpecGx LLC | fentanyl citrate | 0406-9202 | AMMONIA |
| SpecGx LLC | fentanyl citrate | 0406-9202 | CITRIC ACID MONOHYDRATE |
| SpecGx LLC | fentanyl citrate | 0406-9202 | DEXTRATES |
| SpecGx LLC | fentanyl citrate | 0406-9202 | FD&C BLUE NO. 1 |
| SpecGx LLC | fentanyl citrate | 0406-9202 | MAGNESIUM STEARATE |
| SpecGx LLC | fentanyl citrate | 0406-9202 | MODIFIED CORN STARCH |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for FENTANYL CITRATE
Excipient focus: ALCOHOL
FENTANYL CITRATE drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | fentanyl citrate | 0406-9202 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing ALCOHOL
Excipient focus: AMMONIA
FENTANYL CITRATE drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | fentanyl citrate | 0406-9202 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing AMMONIA
Excipient focus: ANHYDROUS CITRIC ACID
FENTANYL CITRATE drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | fentanyl citrate | 0093-7865 |
| Mayne Pharma | fentanyl citrate | 51862-634 |
| Cephalon LLC | fentanyl citrate | 63459-502 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: CELLULOSE, MICROCRYSTALLINE
FENTANYL CITRATE drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Sentynl Therapeutics Inc | fentanyl citrate | 42358-100 |
| Galena Biopharma Inc | fentanyl citrate | 57881-331 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID
FENTANYL CITRATE drug variants containing CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| HJ Harkins Company Inc | fentanyl citrate | 52959-549 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing CITRIC ACID
Excipient focus: CITRIC ACID MONOHYDRATE
FENTANYL CITRATE drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | fentanyl citrate | 0406-9202 |
| Physicians Total Care Inc | fentanyl citrate | 54868-6025 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CROSCARMELLOSE SODIUM
FENTANYL CITRATE drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Sentynl Therapeutics Inc | fentanyl citrate | 42358-100 |
| Galena Biopharma Inc | fentanyl citrate | 57881-331 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: DEXTRATES
FENTANYL CITRATE drug variants containing DEXTRATES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | fentanyl citrate | 0093-7865 |
| SpecGx LLC | fentanyl citrate | 0406-9202 |
| HJ Harkins Company Inc | fentanyl citrate | 52959-549 |
| Physicians Total Care Inc | fentanyl citrate | 54868-6025 |
| Cephalon LLC | fentanyl citrate | 63459-502 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing DEXTRATES
Excipient focus: FD&C BLUE NO. 1
FENTANYL CITRATE drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | fentanyl citrate | 0406-9202 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing FD&C BLUE NO. 1
Excipient focus: HYDROCHLORIC ACID
FENTANYL CITRATE drug variants containing HYDROCHLORIC ACID
FENTANYL CITRATE drug variants not containing HYDROCHLORIC ACID
Excipient focus: MAGNESIUM STEARATE
FENTANYL CITRATE drug variants containing MAGNESIUM STEARATE
FENTANYL CITRATE drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
FENTANYL CITRATE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Sentynl Therapeutics Inc | fentanyl citrate | 42358-100 |
| Archimedes Pharma US Inc | fentanyl citrate | 51772-311 |
| Mayne Pharma | fentanyl citrate | 51862-634 |
| Galena Biopharma Inc | fentanyl citrate | 57881-331 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing MANNITOL
Excipient focus: MODIFIED CORN STARCH
FENTANYL CITRATE drug variants containing MODIFIED CORN STARCH
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | fentanyl citrate | 0093-7865 |
| SpecGx LLC | fentanyl citrate | 0406-9202 |
| HJ Harkins Company Inc | fentanyl citrate | 52959-549 |
| Physicians Total Care Inc | fentanyl citrate | 54868-6025 |
| Cephalon LLC | fentanyl citrate | 63459-502 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing MODIFIED CORN STARCH
Excipient focus: PECTIN
FENTANYL CITRATE drug variants containing PECTIN
| Company | Ingredient | NDC |
|---|---|---|
| Archimedes Pharma US Inc | fentanyl citrate | 51772-311 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing PECTIN
Excipient focus: PHENYLETHYL ALCOHOL
FENTANYL CITRATE drug variants containing PHENYLETHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Archimedes Pharma US Inc | fentanyl citrate | 51772-311 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing PHENYLETHYL ALCOHOL
Excipient focus: PROPYLENE GLYCOL
FENTANYL CITRATE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | fentanyl citrate | 0406-9202 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
FENTANYL CITRATE drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Archimedes Pharma US Inc | fentanyl citrate | 51772-311 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing PROPYLPARABEN
Excipient focus: SHELLAC
FENTANYL CITRATE drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | fentanyl citrate | 0406-9202 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing SHELLAC
Excipient focus: SODIUM BICARBONATE
FENTANYL CITRATE drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | fentanyl citrate | 51862-634 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing SODIUM BICARBONATE
Excipient focus: SODIUM CARBONATE
FENTANYL CITRATE drug variants containing SODIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | fentanyl citrate | 51862-634 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing SODIUM CARBONATE
Excipient focus: SODIUM HYDROXIDE
FENTANYL CITRATE drug variants containing SODIUM HYDROXIDE
FENTANYL CITRATE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM PHOSPHATE, DIBASIC
FENTANYL CITRATE drug variants containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | fentanyl citrate | 0406-9202 |
| HJ Harkins Company Inc | fentanyl citrate | 52959-549 |
| Physicians Total Care Inc | fentanyl citrate | 54868-6025 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing SODIUM PHOSPHATE, DIBASIC
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
FENTANYL CITRATE drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | fentanyl citrate | 0093-7865 |
| Cephalon LLC | fentanyl citrate | 63459-502 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
FENTANYL CITRATE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | fentanyl citrate | 51862-634 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
FENTANYL CITRATE drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | fentanyl citrate | 0406-9202 |
| >Company | >Ingredient | >NDC |
FENTANYL CITRATE drug variants not containing STARCH, CORN
Excipient focus: SUCROSE
FENTANYL CITRATE drug variants containing SUCROSE
FENTANYL CITRATE drug variants not containing SUCROSE
Excipient focus: WATER
FENTANYL CITRATE drug variants containing WATER
FENTANYL CITRATE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links